Back
Keros Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
KROS
Keros Therapeutics, Inc.
Last Price:
$21.34
Seasonality Move:
4.91%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.
Keros Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.03 | Buy |
| 20-day SMA: | 20.05 | Buy |
| 50-day SMA: | 17.55 | Buy |
| 200-day SMA: | 14.85 | Buy |
| 8-day EMA: | 20.95 | Buy |
| 20-day EMA: | 20.1 | Buy |
| 50-day EMA: | 18.36 | Buy |
| 200-day EMA: | 18.72 | Buy |
Keros Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.06 | Buy |
| Relative Strength Index (14 RSI): | 65.11 | Buy |
| Chaikin Money Flow: | 23891 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.46 - 21.46) | Buy |
| Bollinger Bands (100): | (14.23 - 18.57) | Buy |
Keros Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Keros Therapeutics, Inc. Stock
Is Keros Therapeutics, Inc. Stock a Buy?
-
Keros Therapeutics, Inc. share price is 21.38 while KROS 8-day simple moving average is 21.03, which is a Buy signal.
-
The stock price of KROS is 21.38 while Keros Therapeutics, Inc. 20-day SMA is 20.05, which makes it a Buy.
-
Keros Therapeutics, Inc. 50-day simple moving average is 17.55 while KROS share price is 21.38, making it a Buy technically.
-
KROS stock price is 21.38 and Keros Therapeutics, Inc. 200-day simple moving average is 14.85, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Buy
62
Keros Therapeutics, Inc. (KROS)
is a Buy
Is Keros Therapeutics, Inc. a Buy or a Sell?
-
Keros Therapeutics, Inc. stock is rated a BuyThe current Keros Therapeutics, Inc. [KROS] share price is $21.38. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Keros Therapeutics, Inc. Stock Info
Market Cap:
651.4M
Price in USD:
21.38
Share Volume:
541K
Keros Therapeutics, Inc. 52-Week Range
52-Week High:
22.55
52-Week Low:
9.12
Buy
62
Keros Therapeutics, Inc. (KROS)
is a Buy
Keros Therapeutics, Inc. Share Price Forecast
-
What is the Keros Therapeutics, Inc. stock price today?The Keros Therapeutics, Inc. stock price is 21.38 USD today.
-
Will KROS stock go up or go down?Keros Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Keros Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics, Inc. is not overvalued.
Is Keros Therapeutics, Inc. Stock a Buy?
-
Keros Therapeutics, Inc. share price is 21.38 while KROS 8-day exponential moving average is 20.95, which is a Buy signal.
-
The stock price of KROS is 21.38 while Keros Therapeutics, Inc. 20-day EMA is 20.10, which makes it a Buy.
-
Keros Therapeutics, Inc. 50-day exponential moving average is 18.36 while KROS share price is 21.38, making it a Buy technically.
-
KROS stock price is 21.38 and Keros Therapeutics, Inc. 200-day simple moving average is 18.72, creating a Buy signal.
Fundamental Analysis of Keros Therapeutics, Inc.
Is Keros Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.45 per share, and a decrease next year of $5.27 per share.
Technical Analysis of Keros Therapeutics, Inc.
Should I short Keros Therapeutics, Inc. stock?
-
KROS Moving Average Covergence Divergence (MACD) indicator is 1.06, suggesting Keros Therapeutics, Inc. is a Buy
-
Keros Therapeutics, Inc. Relative Strength Index (RSI) is 65.11, which suggest Keros Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Keros Therapeutics, Inc. is (17.46 - 21.46), which suggest Keros Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Keros Therapeutics, Inc. is (14.23 - 18.57), which suggest Keros Therapeutics, Inc. is a Buy
* Keros Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.